Article
Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical case
2025-10-31
Abstract excerpt
<title>Abstract</title> <p>Tedizolid (TDZ) is a second-generation oxazolidinone with potent activity against multidrug-resistant Gram-positive pathogens and a favorable hematologic safety profile compared to linezolid (LNZ). This review summarizes current evidence on TDZ pharmacokinetics, pharmacodynamics, and its reduced risk of thrombocytopenia. We also report a clinical case of a hematologic patient treated wi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4abace5-a57a-5266-b8d2-47cd9a2daea4
- DOI
- 10.21203/rs.3.rs-7809956/v1
